Source author record

Werner Vach

Werner Vach appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

Catalog footprint

What is connected

2works
2topics
4close collaborators

Actions

Connect this record

Log in to claim

Research graph

See the researcher in context

Open full explorer

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2016arXiv

Adapting censored regression methods to adjust for the limit of detection in the calibration of diagnostic rules for clinical mass spectrometry proteomic data

Despite the recent advances in mass spectrometry (MS), summarizing and analyzing high-throughput mass-spectrometry data remains a challenging task. This is, on the one hand, due to the complexity of the spectral signal which is measured, and on the other, due to the limit of detection (LOD). The LOD is related to the limitation of instruments in measuring markers at a relatively low level. As a consequence, the outcome data set from the quantification step of proteomic analysis often consists of a reduced list of peaks where any peak intensities below the detection limit threshold are reported as missings. In this work, we propose the use of censored data methodology to handle spectral measurements within the presence of LOD, recognizing that those have been censored due to left-censoring mechanisms on low-abundance proteins. We apply this approach to the particular problem of calibrating prediction rules through prior estimation of the average isotope expression in MALDI-FTICR mass-spectrometry data, collected in the context of a pancreatic cancer case-control study. Our idea is to replace the set of incomplete spectral measurements with the average intensity estimates and use those as new input to a prediction model. We evaluate the proposed methods, with respect to their predictive ability, by comparing their performance with the one achieved using the complete information as well as alternative/competitive methods to deal with the LOD.

preprint2016arXiv

Statistical development and assessment of summary measures to account for isotopic clustering of Fourier transform mass spectrometry data in clinical diagnostic studies

Mass spectrometry based clinical proteomics has emerged as a powerful tool for highthroughput protein profiling and biomarker discovery. Recent improvements in mass spectrometry technology have boosted the potential of proteomic studies in biomedical research. However, the complexity of the proteomic expression introduces new statistical challenges in summarizing and analyzing the acquired data. Statistical methods for optimally processing proteomic data are currently a growing field of research. In this paper we present simple, yet appropriate methods to preprocess, summarize and analyze high-throughput MALDI-FTICR mass spectrometry data, collected in a case-control fashion, while dealing with the statistical challenges that accompany such data. The known statistical properties of the isotopic distribution of the peptide molecules are used to preprocess the spectra and translate the proteomic expression into a condensed data set. Information on either the intensity level or the shape of the identified isotopic clusters is used to derive summary measures on which diagnostic rules for disease status allocation will be based. Results indicate that both the shape of the identified isotopic clusters and the overall intensity level carry information on the class outcome and can be used to predict the presence or absence of the disease.